AFLURIA QUADRIVALENT (Seqirus Pty Ltd)
Welcome to the PulseAid listing for the AFLURIA QUADRIVALENT drug offered from Seqirus Pty Ltd. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Seqirus Pty Ltd |
| NON-PROPRIETARY NAME: | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VI |
| SUBSTANCE NAME: | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VI |
| TYPE: | VACCINE |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-09-28 |
| END MARKETING DATE: | 0000-00-00 |
AFLURIA QUADRIVALENT VACCINE Details:
| Item Description | AFLURIA QUADRIVALENT from Seqirus Pty Ltd |
| LABELER NAME: | Seqirus Pty Ltd |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15; 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL) |
| START MARKETING DATE: | 2016-09-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 33332-317_05e139ee-fc74-481e-be2b-8dbaa34390b0 |
| PRODUCT NDC: | 33332-317 |
| APPLICATION NUMBER: | BLA125254 |
Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VI Pharmaceutical Manufacturers / Labelers:
